As our interventional data implied, altering the EpFA-signature in the prenephritic lupus prone mice by inhibition of sEH led to a significant improvement of survival and a transient reduction of proteinuria (Fig. 2). The gene discussed is EPHX2; the disease is systemic lupus erythematosus.